SSG
KRTX

Summit Securities Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Summit Securities Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$63K – 991
2023
Q4 		$63K Buy
+200
New +$38.9K 0.01% 377

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Summit Securities Group's KRTX Position: Q1 2024 in Review

Summit Securities Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 200 shares — an estimated $63K sold.

Summit Securities Group first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $63K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Summit Securities Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Summit Securities Group sold 200 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $63K.
  • Summit Securities Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Summit Securities Group's Karuna Therapeutics, Inc. Common Stock position peaked at $63K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Summit Securities Group's 13F filing for Q1 2024, filed 13 May 2024.